Zdrowie i gospodarka · 28/03/2016

FDA Hosts Public Workshop on Safety Biomarkers in Drug Development

The FDA's Center for Drug Evaluation and Research is co-sponsoring a public workshop with the Critical Path Institute to discuss the role of safety biomarkers in the drug development process, focusing on their application in toxicometrics, nonclinical species, and assay validation.